Precision Nudging Drives Wellness Visit Attendance at Scale

January 16, 2024 updated by: Lirio

Employing Machine Learning and Behavioral Science Solutions to Increase Women's Wellness Scheduling and Attendance: A Randomized Controlled Trial

The purpose of the present randomized controlled trial is to explore the effectiveness of a 12-month well woman digital health intervention leveraging Precision Nudging - the application of behavioral science and reinforcement learning to create individualized, tailored health messaging at scale that matches the right message to the right person at the right time - in promoting behavior change. Specifically, it is hypothesized that scaling behavioral science through reinforcement learning will be more effective at motivating participants to engage with well woman messages and to schedule and to attend a well woman visit compared to a standard of care message.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30068

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 14617
        • Rochester Regional Health

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Patient of health care system.
  • Visit with OBGYN office in the last 36 months.
  • OBGYN office provider is a Women's Wellness group approved provider.

Exclusion Criteria:

  • Completed a women's wellness within the last 366 days.
  • Upcoming women's wellness appointment.
  • Had a childbirth episode (e.g., C-section vaginal delivery, or other event, including stillbirth) within the last 3 months or has a pregnancy due date in the future.
  • Unsubscribed.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Treatment
Behavioral science and reinforcement learning-driven hyper-personalized messages
Precision nudging (i.e., the application of behavioral science and reinforcement learning to create individualized, tailored health messaging at scale that matches the right message to the right person at the right time)
Active Comparator: Control
Standard of care message
Standard of care communication (e.g., personalized letters and patient portal notices)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Proportion of participants who attended a well woman visit
Time Frame: 3 months
3 months
Proportion of participants who attended a well woman visit
Time Frame: 6 months
6 months
Proportion of participants who attended a well woman visit
Time Frame: 9 months
9 months
Proportion of participants who attended a well woman visit
Time Frame: 12 months
12 months
Proportion of participants who scheduled a well woman visit
Time Frame: 3 months
3 months
Proportion of participants who scheduled a well woman visit
Time Frame: 6 months
6 months
Proportion of participants who scheduled a well woman visit
Time Frame: 9 months
9 months
Proportion of participants who scheduled a well woman visit
Time Frame: 12 months
12 months
Proportion of participants who scheduled a well woman visit and did not attend (and did not Cancel and/or Reschedule)
Time Frame: 3 months
3 months
Proportion of participants who scheduled a well woman visit and did not attend (and did not Cancel and/or Reschedule)
Time Frame: 6 months
6 months
Proportion of participants who scheduled a well woman visit and did not attend (and did not Cancel and/or Reschedule)
Time Frame: 9 months
9 months
Proportion of participants who scheduled a well woman visit and did not attend (and did not Cancel and/or Reschedule)
Time Frame: 12 months
12 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Proportion of participants who opened and/or clicked Call-to-Action, or otherwise engaged with the communication(s)
Time Frame: 3 months
3 months
Proportion of participants who opened and/or clicked Call-to-Action, or otherwise engaged with the communication(s)
Time Frame: 6 months
6 months
Proportion of participants who opened and/or clicked Call-to-Action, or otherwise engaged with the communication(s)
Time Frame: 9 months
9 months
Proportion of participants who opened and/or clicked Call-to-Action, or otherwise engaged with the communication(s)
Time Frame: 12 months
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Laurie Ernest, DNP, BSN, MS, WHNP-C, Rochester Regional Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 7, 2022

Primary Completion (Actual)

January 9, 2024

Study Completion (Actual)

January 9, 2024

Study Registration Dates

First Submitted

August 17, 2022

First Submitted That Met QC Criteria

August 17, 2022

First Posted (Actual)

August 19, 2022

Study Record Updates

Last Update Posted (Estimated)

January 17, 2024

Last Update Submitted That Met QC Criteria

January 16, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • LRRHWWRCT
  • IRB 2129 (Other Identifier: Rochester Regional Health Institutional Review Board)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health Behavior

Clinical Trials on Precision nudging

Subscribe